TELUS Health Solutions and Orange have joined forces to develop innovative remote monitoring solutions for patients with chronic diseases. The Calydial solution, a pilot that remotely monitored patients with kidney disease, in collaboration with Grenoble University Hospital, Calydial dialysis centers of Lyon, France and AGDUC health center in Grenoble, France, yielded positive results; patient satisfaction and patient support both improved 1. Yesterday, the Calydial solution was awarded the Innovation Prize in the telemedicine category at Health IT, France’s preeminent information technology trade show for hospitals and other medical establishments.
In this pilot, patients living with chronic kidney disease were selected by a team of professionals from Calydial and AGDUC to take part in a trial using the TELUS and Orange remote patient monitoring (RPM) solution at home. Patients were given a tablet computer, connectivity and software to monitor their vital signs, manage their medication and treatment protocols and provide feedback to their care team. Early positive results have demonstrated the potential to replicate this solution across other institutions and for other chronic diseases thanks to the ergonomic and reliable solution.
The Calydial solution uses the TELUS RPM solution, a network-centric, multi-function application that allows patients with conditions that require daily monitoring to coordinate with their healthcare providers from home. As the technical lead, Orange worked with Calydial, AGDUC and the Grenoble University Hospital to define, deploy and test the solution. Patients and caregivers are able to access the application through secure Orange wireline and wireless networks.
The agreement between TELUS and Orange reflects the mutual objectives of both companies to develop telemedicine technology and applications that help to improve the quality of patient care, reduce system costs and provide healthcare teams with enhanced access to patient health information for better decision-making and chronic disease management.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts